AbCellera Biologics Inc vs Motorola Solutions Inc — how do they compare? AbCellera Biologics Inc trades at $9.07 (market cap $2.99B), while Motorola Solutions Inc trades at $466.86 (market cap $77.26B). The key difference: Motorola Solutions Inc is far larger — about 25.8× AbCellera Biologics Inc's market cap, and Motorola Solutions Inc pays a 1.04% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MSI | |
|---|---|---|
Market Cap | $2.99B | $77.26B |
Sector | Health | Technology |
52-Week High | $9.76 | $490.30 |
52-Week Low | $2.78 | $363.83 |
Enterprise Value | $2.58B | $86.17B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →